Low-dose natural antimicrobial exacerbates chronic lung infection in cystic fibrosis
Main Points: Respiratory failure caused by chronic lung infection with Pseudomonas aeruginosa bacteria is a common cause of death in patients with
Read morecystic fibrosis
FDA has approved Kalydeco; a drug for the treatment of cystic fibrosis
U.S. Food and Drug Administration (FDA) has approved “Kalydeco or VX-770” (ivacaftor) by Vertex Pharmaceuticals as reported by the company
Read more